
A detailed study by Oak Ridge National Laboratory estimated how much more—or less—energy United States residents might consume by 2050 relative to predicted shifts in seasonal weather patterns
A detailed study by Oak Ridge National Laboratory estimated how much more—or less—energy United States residents might consume by 2050 relative to predicted shifts in seasonal weather patterns
Scientists at Oak Ridge National Laboratory studying quantum communications have discovered a more practical way to share secret messages among three parties, which could ultimately lead to better cybersecurity for the electric grid
A study led by Oak Ridge National Laboratory explored the interface between the Department of Veterans Affairs’ healthcare data system and the data itself to detect the likelihood of errors and designed an auto-surveillance tool
Oak Ridge National Laboratory is using artificial intelligence to analyze data from published medical studies associated with bullying to reveal the potential of broader impacts, such as mental illness or disease.
Scientists at Oak Ridge National Laboratory have developed a low-cost, printed, flexible sensor that can wrap around power cables to precisely monitor electrical loads from household appliances to support grid operations.
Using artificial neural networks designed to emulate the inner workings of the human brain, deep-learning algorithms deftly peruse and analyze large quantities of data.
Three ORNL computer scientists headed the 2018 DOE ASCR Basic Research Needs Workshop on Extreme Heterogeneity and development of its final report.
OAK RIDGE, Tenn., March 13, 2019 – Two technologies from the Department of Energy’s Oak Ridge National Laboratory have received national Excellence in Technology Transfer awards from the Federal Laboratory Consortium for Technology Transfer: “Qrypt Lice
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.